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Abstract 
Background: Elevated blood pressure (BP) is the single greatest cardiovascular risk factor 
worldwide. Hypertension management is guided by brachial cuff BP, but questions have been 
raised regarding accuracy. 
Objectives: To determine the accuracy of cuff BP and the consequent impact on BP 
classification compared with intra-arterial BP reference standards. 
Methods: Three separate, but closely related, individual participant data meta-analyses were 
conducted among studies (from the 1950’s to 2016) that measured intra-arterial aortic BP, intra-
arterial brachial BP and cuff BP. 
Results: Total studies and participants were n=74 and n=3,073. Intra-arterial brachial systolic 
BP (SBP) was higher, and intra-arterial brachial diastolic BP was lower than aortic values (8.0 
mmHg, 95%CI 5.9 to 10.1; p<0.0001; -1.0 mmHg, 95%CI -2.0 to -0.1; p=0.038 respectively). 
Cuff BP underestimated intra-arterial brachial SBP but overestimated intra-arterial diastolic BP 
(-5.7 mmHg, 95%CI -8.0 to -3.5, p<0.0001; 5.5 mmHg, 95%CI 3.5 to 7.5, p<0.0001). Cuff and 
intra-arterial aortic SBP showed a small mean difference (0.3 mmHg, 95%CI -1.5 to 2.1, p=0.77) 
but poor agreement (mean absolute difference 8.0 mmHg, 95%CI 7.1 to 8.9). Concordance 
between BP classification using JNC7 cuff BP (normal, prehypertension, hypertension stages 1 
and 2) compared with intra-arterial brachial BP was 60%, 50%, 53% and 80%, and for intra-
arterial aortic BP was 79%, 57%, 52% and 76%. Using revised intra-arterial thresholds based on 
cuff BP percentile rank, concordance between BP classification using cuff BP compared with 
intra-arterial brachial BP was 71%, 66%, 52% and 76%, and for intra-arterial aortic BP was 
74%, 61%, 56% and 65%. 
 
Conclusions: Cuff BP has variable accuracy for measuring either brachial or aortic intra-arterial 
BP, and this adversely influences correct BP classification. These findings do not undermine the 
well-established clinical importance of cuff BP, but indicate that stronger accuracy standards for 
BP devices may improve cardiovascular risk management. 
 
Keywords: blood pressure determination, sphygmomanometers, hemodynamics 
 
Abbreviations 
BP = blood pressure 
SBP = systolic blood pressure 
DBP = diastolic blood pressure 
PP = pulse pressure 
JNC 7 = Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High 
Blood Pressure 7 
 
Condensed Abstract: Cuff BP is the principal method for hypertension management, however, 
questions have been raised regarding accuracy. We performed the first comprehensive analysis 
of cuff BP compared with intra-arterial BP, via three individual participant data meta-analyses. 
The key finding was cuff BP has variable accuracy for measuring either brachial or aortic intra-
arterial BP. This adversely affects cuff BP classification, particularly for prehypertension and 
stage one hypertension. The clinical importance of cuff BP is unquestionable, but our findings 
suggest that improved accuracy standards for BP devices is desirable and this may improve 
cardiovascular risk management.  
Introduction 
Cardiovascular disease is the number one cause of mortality worldwide, with elevated 
blood pressure (BP) as the single largest risk factor (1-3). Non-invasive brachial (upper arm) cuff 
BP is the principal method for hypertension diagnosis and management, thus, accurate BP 
measurement is amongst the most important medical tests performed (4). Importantly, even 
relatively small error in cuff BP measurement can have major public health ramifications, with 
an inaccuracy of 5 mmHg estimated to result in the misclassification of BP among 48 million 
people each year in the United States alone (21 million related to BP underestimation, 27 million 
related to overestimated BP) (5). On the one hand, BP underestimation leads to missed 
therapeutic potential and unnecessary elevation of cardiovascular risk (6), whereas BP 
overestimation creates unnecessary additional cost and exposure to possible adverse effects of 
treatment (5). The recognition of prehypertension as a non-benign clinical presentation (7), and 
the benefit to some patient populations of achieving low BP targets (8) further emphasizes the 
need for accurate cuff BP across the range of BP classifications. 
Several lines of evidence place a question mark over the accuracy of cuff BP. Firstly, 
many small studies indicate a possible bias for cuff BP to underestimate intra-arterial brachial 
systolic BP (SBP), yet overestimate intra-arterial brachial diastolic BP (DBP) and, thereby, 
underestimate intra-arterial pulse pressure (PP) (9-11). Secondly, cuff BP devices being tested 
for accuracy against other non-invasive measurements according to international validation 
protocols may perform to a “pass” standard even when clinically significant measurement errors 
occur among many patients (12). Thirdly, there can be large individual variability in intra-arterial 
BP between the aorta and brachial artery (9,13,14), but whether oscillometric or auscultatory cuff 
BP accurately measures either aortic or brachial BP has never been systematically determined. 
This is important to resolve given the possibility that aortic BP is more clinically relevant than 
brachial BP (13,15-17), and the burgeoning of commercial devices purporting to measure aortic 
BP (18) to enable (theoretical) better assessment of risk related to BP.(19) However, this is a 
controversial concept (20,21) in which some investigators advocate there is a lack of evidence to 
justify the need to depart from standard cuff BP (20,22). Adding to this debate is the suggestion 
that brachial cuff BP may already appropriately measure aortic BP, eliminating the need for 
specialist devices (23-25). 
The issues detailed above create uncertainty as to whether cuff BP accurately measures 
intra-arterial BP, either at the brachial or aortic level. Better understanding of these issues is 
highly relevant to validation protocol standards for cuff BP devices and could ultimately lead to 
improved clinical management of cardiovascular risk through more accurate BP measurement 
and classification. To address key knowledge deficits, we completed a series of three separate 
but interrelated systematic reviews and individual participant data meta-analyses to determine 
the accuracy of cuff BP methods. We firstly aimed to determine the true level of intra-arterial BP 
between the aorta and brachial artery (meta-analysis 1), and then whether cuff BP accurately 
measured either intra-arterial brachial BP (meta-analysis 2) or intra-arterial aortic BP (meta-
analysis 3). The potential clinical consequences of cuff BP measurement error were determined 
by the concordance between cuff BP and intra-arterial BP for BP classification according to 
criteria of The Seventh Report of the Joint National Committee on Prevention, Detection, 
Evaluation, and Treatment of High Blood Pressure (JNC 7) (26). 
Methods 
Search technique and study eligibility 
The search technique, study eligibility criteria, data collection, synthesis and statistical 
analysis were conducted similarly across each meta-analysis, with minor differences reflecting 
the specific needs of each meta-analysis question. Preferred Reporting Items for Systematic 
Review and Meta-Analyses of individual participant data (PRISMA-IPD) (Online Table 1) (27). 
Two reviewers (D.S.P, M.G.S) identified eligible studies by title, abstract or full-text review and 
performed a separate data quality assessment. All these activities were undertaken with each 
reviewer blinded to the others results. Discrepancies were resolved via consensus. In the interests 
of focusing on the results of cuff BP compared with intra-arterial BP, the results from meta-
analysis 1 are provided in the online supplement. 
Four online databases (PubMed, Scopus, Embase and Web of Knowledge) were 
systematically searched for eligible articles from database inception until 9 May 2016, with 
slight modifications for each meta-analysis (Online Table 2). Additional studies were found by 
searching the reference lists of identified studies and personal communication with authors. 
Unpublished data was accepted if sufficient methodology was provided (Online Appendix 1). 
Study eligibility was not restricted by subject age, language or year of publication. We included 
studies that measured intra-arterial BP by high-fidelity micromanometer tip or fluid-filled 
catheters, as well as indwelling arterial needles and cannulas. For each meta-analysis, studies 
were only included if the BP measurements being compared were recorded within the immediate 
period of each other, rather than at different times (28), due to possible haemodynamic changes 
between measurement periods (29). Studies that measured BP at multiple arterial sites (e.g. 
brachial and radial) in the same study were included if authors were able to provide separated 
data. Studies that recorded data under non-basal conditions involving haemodynamic shifts (e.g. 
exercise or administration of vasoactive drugs that altered BP during the recording procedure) 
were excluded. There was some minor variability of the inclusion and exclusion criteria that 
were specific to the goal of each meta-analysis. These included cuff BP methods of auscultation 
(mercury or aneroid), oscillometric and automatic Korotkoff sound devices for meta-analyses 2 
and 3. Studies were also excluded if the goal of the work was to determine the effect of different 
cuff sizes on the relationship between cuff BP and intra-arterial BP because of the expectation of 
cuff BP measurement error (30). For meta-analyses 1 and 3, studies that measured aortic BP 
distal to the aortic arch were excluded due to potential amplification of SBP along the aorta (31) 
contributing to discordance of comparison between BP measurements.  
Data collection 
For each eligible study, individual participant level de-identified BP data were requested 
from authors. PP was calculated as SBP – DBP. Clinical information including age, sex, 
anthropometry, medications and disease status were also requested if available. Data in non-SI 
format were standardised to SI units, except for pressure units. Individual data supplied by 
authors were checked for consistency with published aggregate data where available, and if 
discrepancies were identified, clarification was sought from authors. If no response was received 
to data requests, or authors were not contactable, individual data were extracted from within 
published tables (Online Appendix 2), or from figure scatterplots using extraction software, 
when possible (32). Data obtained from scatterplots were only included in the meta-analyses 
when accuracy could be verified by comparison with published summary data or correlation 
coefficients (Online Table 3). A quality score was applied to each study in order to account for 
important study design attributes that may have impacted on data quality (Online Appendix 3 
and Tables 4-6). The University of Tasmania Health and Medical Human Research Ethics 
Committee approved the study (reference: H0015048). 
Magnitude of BP differences 
The proportion of cuff BP measurements that were ≥5, ≥10 or ≥15 mmHg different from 
intra-arterial BP were determined as a measure of accuracy (33). 
BP classification 
To determine accuracy of cuff BP for BP classification, each individuals cuff BP was 
classified according to JNC 7 criteria (normal BP <120/80 mmHg, prehypertension SBP 120-139 
or DBP 80-89 mmHg, stage 1 hypertension SBP 140-159 or DBP 90-99 mmHg and stage 2 
hypertension SBP ≥160 or DBP ≥100 mmHg),(26) and then compared for concordance with the 
BP classification according to the measurement of BP by intra-arterial brachial and aortic BP. 
For example, for an individual with cuff BP classified as normal (<120/80 mmHg), the 
corresponding intra-arterial BP for that individual was classified into the appropriate category 
(e.g. normal, prehypertension, stage 1 or 2 hypertension), and found to be concordant if also 
falling into the same normal BP classification (<120/80 mmHg). This approach enabled an 
assessment of the potential impact of cuff BP inaccuracy on clinical practice, but also recognizes 
a level of arbitrariness with BP cut points because there is a continuous relationship between BP 
and cardiovascular risk. Additional analyses were also undertaken in which the risk cut points for 
intra-arterial BP (both brachial and aortic) were drawn at equal percentile ranks to the traditional 
cuff BP cut points. Sensitivity and specificity of cuff BP for delineating hypertension at a cut 
point of ≥140/90 mmHg was also assessed. 
Statistical analysis 
BP and clinical characteristics are presented as mean and 95% confidence interval (95% 
CI) unless otherwise specified. BP differences were calculated as brachial artery BP minus aortic 
BP (meta-analysis 1) and cuff BP minus intra-arterial brachial or aortic BP (meta-analysis 2 and 
3). Both one-stage and two-stage meta-analysis were used. The results generated from each 
method are considered equivalent in individual participant data meta-analysis (34). Two-stage 
meta-analyses were used to analyse mean BP differences because this method allowed 
production of summary forest plots to illustrate the level of the BP difference across included 
studies. For this method, data were first analyzed study by study and then synthesised using 
random effects meta-analysis due to the observational nature of the data. Pooled Ccorrelation 
coefficients from individual studies were used to calculate summary correlation coefficients 
regarding on the relationship between BP measurements in each meta-analysis. This same 
method was used for sensitivity and specificity analyses for cuff BP delineating hypertension 
based on the 140/90 mmHg cut point. Linear mixed modelling (one-stage meta-analysis) was 
used to account for clustering of individuals within each study for mean absolute difference, BP 
classification analysis, percentile calculation for the revised intra-arterial BP thresholds and 
potential predictors of BP differences. Mean absolute difference was calculated as the absolute 
value of the BP difference at the individual participant level. In meta-analysis 3, Laugesen et al 
(35) and Rossen et al (36) were pooled for analysis because participants were from the same 
population, and the measurement protocols used were identical, except for the type of cuff BP 
device. 
Sensitivity analyses were among studies that received the maximum study quality score 
to assess whether results were influenced by study design factors and separately to assess 
published, compared with unpublished data sources. Furthermore, to determine the influence on 
results of meta-analyses 2 and 3, sensitivity analyses were conducted for single compared with 
the average of multiple cuff BP measures, as well as the type of catheter used for intra-arterial 
BP measurement. P values <0.05 were considered statistically significant. Data were synthesized 
and analyzed using R, version 3.1.2, R Core Team (2014), primarily using the metafor and lme4 
packages and Stata 14, StataCorp (2015; metandi module). Additional statistical methods are 
detailed in Online Appendix 4. 
Results 
Eligible studies and subject characteristics 
A total of 75,071 studies were identified from the three meta-analysis searches. After 
review based on title and abstract, 371 studies were full-text reviewed and 152 of these were 
eligible for inclusion in the meta-analyses. Individual participant data were not available from 7, 
49 and 23 studies for meta-analyses 1, 2 and 3 respectively, leaving 13 studies (9,11,13,14,37-
42), 22 studies (43), and 39 studies (9,11,24,35,36,38,41,44-70) for SBP analysis, whereas 12 
studies (11,13,14,37-42), 18 studies (10,11,38,41,47,71-80), and 36 studies (11,35,36,38,41,44-
60,62-70) were available for analysis relating to DBP and PP (see Online Tables 7-10 and Online 
References). Systematic review flow diagrams and study characteristics for all meta-analyses are 
detailed in Online Figures 1-6 and Tables 7-12. Data were extracted from published tables in 101 
studies (Online Appendix 2), (10,13,14,39,46,53,71-73,79,80) and from published figures in 65 
studies (Online Table 3) (9,24,81-83). Data was sourced from 18 countries (Australia, New 
Zealand, China, Japan, Singapore, United States, Canada, England, Scotland, France, Germany, 
Italy, Austria, Portugal, The Netherlands, Denmark, Norway and Israel). Across the three meta-
analyses, subjects were generally middle-older aged, predominately male and overweight 
according to body mass index (Online Tables 13-15). When individual participant data were 
checked as per guidelines (27), no important issues, such as inconsistency with published 
aggregate data arose. There were minor differences between the number of subjects in some 
published articles and the number of subjects used in the meta-analyses (reasons for this are 
explained in Online Appendix 5). 
Meta-analyses on BP differences 
See online supplementary material for all results from In meta-analysis 1 (Online 
Appendix 6 and Online Figures 7-9). brachial artery SBP was significantly higher than aortic 
SBP and PP (p<0.0001; Figure 1A, C). On the other hand, brachial DBP was marginally, but 
significantly lower than aortic DBP (p=0.038; Figure 1B). The range of differences for SBP, 
DBP and PP was large (-9 to 62 mmHg, -22 to 25 mmHg and -17 to 62 mmHg respectively, 
Online Figure 7). The pooled correlation coefficients showed strong associations between intra-
arterial brachial and aortic SBP (r=0.92, 95%CI 0.88 to 0.95), DBP (r=0.93, 95%CI 0.91 to 0.95) 
and PP (r=0.89, 95%CI 0.86 to 0.93, p<0.0001 all, Online Figure 8).  
In meta-analysis 2, brachial cuff BP methods significantly underestimated intra-arterial 
brachial SBP and PP, but significantly overestimated intra-arterial brachial DBP (p<0.0001 all, 
Figure 12A-C). The mean absolute difference for SBP was 7.9 mmHg, 95% confidence interval 
(95%CI) 6.5 to 9.5. Intra-arterial brachial SBP was underestimated among studies that used 
either oscillometric or mercury sphygmomanometric techniques, albeit only of borderline 
significance for the latter (Online Table 16). However, both oscillometric and mercury 
sphygmomanometric cuff methods significantly overestimated intra-arterial brachial DBP and, 
therefore, also significantly underestimated intra-arterial brachial PP. Strong correlations were 
observed between brachial cuff and intra-arterial brachial SBP (r=0.89, 95%CI 0.86 to 0.93), 
DBP (r=0.78, 95%CI 0.72 to 0.85) and PP (r=0.82, 95%CI 0.76 to 0.88, p<0.0001 all, Online 
Figure 109). 
In meta-analysis 3, there was no significant difference between brachial cuff and intra-
arterial aortic SBP (Figure 23A, p=0.77), however, this was due to a relative balance in the 
number of studies reporting either significant overestimation (7 studies) or significant 
underestimation (7 studies) of intra-arterial aortic SBP by cuff SBP. Indeed, the mean absolute 
difference was 8.0 mmHg (95%CI) 7.1 to 8.9. Brachial cuff methods significantly overestimated 
intra-arterial aortic DBP and, thus, significantly underestimated intra-arterial aortic PP (Figure 
23B and C, p<0.0001 both). Oscillometric and mercury sphygmomanometric cuff methods were 
not analysed separately like meta-analysis 2, because the mercury method was only used in 2 
studies, totalling 21 individuals. There were strong relationships between brachial cuff and intra-
arterial aortic SBP based on the pooled correlation coefficients (r=0.88, 95%CI 0.86 to 0.90), 
DBP (r=0.75, 95%CI 0.70 to 0.80) and PP (r=0.81, 95%CI 0.76 to 0.85, p<0.0001 all, Online-
only Figure 101). In all three meta-analyses there was significant heterogeneity between studies 
for the SBP, DBP and PP analyses (I2>86%, p<0.0001 all). 
BP classification based on brachial cuff BP compared with intra-arterial BP 
Among individuals with BP classified as either prehypertension or stage 1 hypertension, 
only 50-60% of brachial cuff BP measures were concordant with intra-arterial BP measures. 
Underestimation of BP classification was the predominant issue for brachial cuff comparisons 
with intra-arterial brachial BP, whereas intra-arterial aortic BP classifications were similarly 
overestimated and underestimated. On the other hand, there was reasonable concordance 
between brachial cuff BP and intra-arterial BP (brachial or aortic) values measured among 
individuals with stage 2 hypertension (≥160/100 mmHg) according to intra-arterial BP. There 
was also reasonable concordance between cuff BP and intra-arterial aortic BP for BP 
classification in the normal range (<120/80 mmHg, Table 1). There were similar findings and 
when BP classification was only based on SBP thresholds (Online Table 17). When revised 
percentile rank intra-arterial BP thresholds were used, there was an improvement in concordance 
compared with the traditional threshold analysis in some BP categories (for example, in meta-
analysis 2, normal and prehypertension categories changed from 60% to 71% and from 50% to 
66%). However, concordance remained similar or was reduced among other categories (Table 
2). The revised thresholds shifted the systematic underestimation of risk using cuff BP compared 
with intra-arterial brachial BP among the categories of prehypertension and stage 1 hypertension 
to a more even distribution of over- and under-estimation of the correct BP classification 
category. For example, in the category of cuff BP prehypertension, the percentage of intra-
arterial brachial BP cases that were in the stage 1 hypertension category reduced from 36% to 
17% (cuff underestimation). However, in the category of cuff BP prehypertension, the 
percentage of intra-arterial brachial BP in the normal category increased from 9% to 13% (cuff 
overestimation). Similarly, in the category of cuff BP stage 1 hypertension, the percentage of 
intra-arterial brachial BP cases that were either in stage 2 hypertension or prehypertension 
categories changed from 32% to 20% (cuff underestimation) and from 13% to 26% (cuff 
overestimation), respectively. With respect to delineating hypertension at the traditional cut point 
of 140/90 mmHg, in meta-analysis 2 sensitivity was 78.5% (95%CI 66.8 to 87.0), whilst 
specificity was 95.2% (95%CI 86.5 to 98.4%). In meta-analysis 3, sensitivity was 81.7% (95%CI 
74.9 to 87.0%) and specificity was 88.5% (95%CI 83.4 to 92.2%). 
Magnitude of difference between cuff and intra-arterial BP 
Brachial cuff BP readings were ≥5, ≥10 or ≥15 mmHg different from intra-arterial 
brachial SBP in 465 (67%), 275 (41%) and 173 (26%) of subjects respectively (Figure 34A). 
Similarly, when compared with intra-arterial aortic BP, brachial cuff SBP was ≥5, ≥10 or ≥15 
mmHg different in 1236 (67%), 748 (40%) and 411 (22%) of subjects respectively (Figure 34B). 
Results were similar for DBP differences, although there was better agreement for DBP 
differences ≥15 mmHg (Online Figure 121). 
Clinical and demographic correlates of brachial cuff and intra-arterial BP differences 
Older age and higher body mass index were related in univariable analysis to less 
underestimation of intra-arterial brachial and aortic SBP and PP by brachial cuff SBP and PP 
(Online Tables 18-19). In multivariable analysis age and body mass index both remained 
significantly related to the difference in PP, but age was not significantly related to the difference 
between brachial cuff and intra-arterial brachial SBP, whilst body mass index was not 
significantly related to the difference between brachial cuff and intra-arterial aortic SBP. There 
were no consistent associations observed for brachial cuff DBP versus intra-arterial DBP. 
Sensitivity analysis 
Participants were significantly older and had higher intra-arterial brachial SBP and intra-
arterial aortic PP in the maximum rated compared to the non-maximum rated studies in meta-
analysis 1. There were significantly more males in the maximum rated studies in meta-analyses 2 
and 3. There were no other significant differences between the maximum rated and non-
maximum rated studies (p>0.05 all, Online Tables 20-22). There were no significant differences 
in BP values for published versus unpublished data (p>0.05, Online Tables 23-25). In meta-
analysis 2 and 3, there were no significant differences when data was analyzed based on single 
cuff BP measures versus the average of multiple cuff BP measures. Correlations between cuff 
and intra-arterial BP were similar irrespective of the number of cuff BP measures as was 
Furthermore, BP classification analysis. was consistent irrespective of the number of cuff 
measures. Differences between cuff and intra-arterial BP were not significantly influenced by the 
type of catheter used for intra-arterial BP measurement (data not shown). 
Discussion 
With hypertension as the single major risk factor for global disease burden,(1) the 
accuracy of clinic BP methods is critical. On the basis of several lines of evidence questioning 
the accuracy of cuff BP, a series of interconnected individual participant meta-analyses were 
performed to interrogate this issue. There were several key findings. Firstly, we confirmed the 
expectation that intra-arterial brachial SBP was higher than intra-arterial aortic SBP, and also 
that there was little difference in DBP between the central and peripheral arterial sites. However, 
there was extreme individual variability in the magnitude of central-to-peripheral differences for 
both SBP and DBP. Second, we found that cuff BP underestimated intra-arterial brachial SBP 
(and PP), but overestimated intra-arterial brachial DBP irrespective of BP technique (e.g. 
oscillometric or auscultation using mercury methods). This is confirmation of perceived dogma 
relating to oscillometric devices but, as far as we know, is the first comprehensive analysis of all 
cuff BP methods to be reported. Thirdly, when cuff SBP was compared with intra-arterial aortic 
SBP, there was a small mean difference but poor agreement between measures at the individual 
level, whereas cuff DBP overestimated and cuff PP underestimated intra-arterial aortic values. 
Finally, the observed variability in cuff BP accuracy adversely influenced correct classification 
of BP (compared against intra-arterial classification) across all JNC 7 categories, with particular 
discordance in the range from prehypertension to stage 1 hypertension. These data do not 
weaken the firmly established evidence on the critical role of cuff measured BP for assessing 
cardiovascular risk, but the findings do indicate the need to improve accuracy standards of cuff 
BP devices. 
Potential cClinical implications 
A key aspiration identified to address the global burden of disease related to high BP is 
improved diagnosis and characterization of the hypertensive phenotype (84). Our findings relate 
directly to this goal because a fundamental problem with BP accuracy was identified that affects 
most (but not all) cuff BP devices, with a key problem being the underestimation of the actual 
risk related to BP. Despite strong correlations between cuff BP and intra-arterial BP, from the 
cuff BP devices examined, 16 out of 22 significantly underestimated intra-arterial brachial SBP 
(Figure 12, panel A) and 15 out of 18 significantly underestimated pulse pressure (Figure 12, 
panel C), with the mean difference in the magnitude of underestimation often exceeding 10 
mmHg. Translating these error margins to the traditional classification of BP based on intra-
arterial SBP readings, cuff BP correctly identified prehypertension and stage 1 hypertension only 
in about half the participants, whether based on intra-arterial brachial or aortic SBP (Table 1, 
panels A and B). Most of the misclassification of intra-arterial brachial BP was due to 
underestimation by cuff BP; for example, 36% of people with stage 1 hypertension were 
misclassified as having prehypertension, and 31% of people with stage 2 hypertension were 
misclassified as having stage 1 hypertension (Table 1, panel A). Concordance with revised 
intra-arterial brachial BP thresholds (based on cuff BP percentile rank) was improved from 50% 
to 66% in the prehypertension range (Tables 1 and 2). This analysis also resulted in less 
propensity toward systematic underestimation of risk using cuff BP among the categories of 
prehypertension and stage 1 hypertension, and instead a relatively even distribution was 
observed towards both over- and under-estimation of correct classification of intra-arterial BP 
(Table 2). The true implications of these findings with respect to identification of risk related to 
BP in clinical practice will need to be gauged in future studies.  speculate that these cuff BP 
inaccuracies could inadvertently underlie the concept of “residual cardiovascular risk” despite 
BP control (85). 
Although the broader clinical impact of cuff BP underestimation is not able to be tested 
within this current analysis, the natural consequence of lower recorded BP in clinical practice is a 
downgrading of risk projection, leading to less incentive for initiation (or uptitration) of therapy 
or lifestyle intervention, and a forgone opportunity to reduce cardiovascular risk. This outcome 
would have wide reaching potential for adverse health and economic effects at the population 
level.(5,86) Then again, aAn argument could be raised against our findings being a major clinical 
problem because hypertension thresholds have been derived from well conducted clinical trial 
data using the same (or similar) cuff BP methods to that analyzed in this current work. Thus, 
whether cuff BP is measuring the intra-arterial BP could be largely irrelevant if risk can still be 
gauged relative to the BP methods employed in the clinical trials. This contention could be valid 
if there were consistent systematic error(s), but in fact there was little uniformity and wide inter-
device variability with respect to SBP, DBP and PP accuracy. To definitively clarify the issue, 
separate analysis on the accuracy of BP devices used in all the seminal clinical trials would need 
to be undertaken. In any case, a reasonable degree of confidence in cuff BP being representative 
of intra-arterial brachial or aortic SBP is provided with readings <120/80 mmHg or ≥160/100 
mmHg (Tables 1 and 2). 
Cuff BP validation standards 
Guidance on validation protocols for cuff BP devices is provided by several scientific 
bodies,(33,87-91) however, there are many procedural differences between guidelines on 
features such as sample size, acceptable margin of error and pass criteria (92). When comparing 
BP device performance with the reference standard (which can be intra-arterial BP or, most 
often, mercury sphygmomanometry), differences of 0 – 5 mmHg are considered to be “very 
accurate,” whereas differences >15 mmHg are “very inaccurate.”(89) Although there are many 
ways to determine pass criteria for BP devices, the British Hypertension Society provide the 
highest grade pass (A) if 60% of differences fall within 5 mmHg and only 5% of differences fall 
outside 15 mmHg (33). The analysis we have conducted cannot be directly compared with 
results of validation studies assessing the performance of individual BP devices. However, it is 
of note that only 33% of cuff SBP readings fell within 0 – 5 mmHg, and >20% were >15 mmHg 
from intra-arterial SBP (Figure 43), which would equate to a grade D (fail) device performance. 
From the available data, weak associations between age, body mass index and cuff BP 
differences were observed in meta-analyses 2 and 3, but we were unable to determine clear-cut 
reasons for the disparity between cuff and intra-arterial BP, and this is an area of future research 
need. 
A novel finding with respect to the use of mercury sphygmomanometry as a reference 
standard in BP validation protocols is that this method was not without sizable imprecision. In 
comparison to intra-arterial brachial BP, the mercury method performed better than oscillometric 
BP with respect to the level of SBP underestimation, but significant overestimation of DBP and 
underestimation of pulse pressure was still observed (Online Table 16). There was insufficient 
data on mercury BP to compare this method with oscillometric BP for accuracy compared to 
intra-arterial aortic BP. Overall the analyses casts some doubt on the robustness of mercury 
sphygmomanometry as the standard against which BP device performance is gauged (possibly 
due to influences of operator error), albeit acknowledging that it is the best non-invasive option 
currently available. Intra-arterial BP measured under rigorous criteria has the strongest level of 
BP accuracy and may be a better choice as the comparator for BP device validation, but is less 
practical and is not ethical to use among some populations. In any case, our observation of 
significant differences (and marked variability) between intra-arterial aortic and brachial BP 
clearly shows that it is not acceptable to assume peripheral BP is representative of central BP, 
which is applicable to BP device validation protocols in which cuff BP is compared against intra-
arterial BP at the radial (93), brachial (10), or aortic (55) level. Improvement of BP device 
accuracy standards is desirable (29). 
Strengths and limitations 
Individual level data were acquired from a wide variety of studies employing high-quality 
techniques and spanning several decades of investigations, altogether comprising relatively large 
sample sizes for each meta-analysis. However, this also probably contributed to the observed 
statistical heterogeneity, indicating excess variation among experimental protocols and a degree 
of uncertainty regarding effect estimates. Further, although intra-arterial BP is regarded as the 
reference standard measurement of BP (94,95), inaccurate BP is still possible via numerous 
sources of error if operators do not follow appropriate techniques (e.g. catheter handling and 
dynamic response),(96) or variability in BP between the recording of cuff and intra-arterial 
measurements, or if measures being compared are recorded sequentially rather than 
simultaneously, or within contralateral rather than ipsilateral arterial sites. Reassuringly, the 
sensitivity analyses showed no significant difference between the studies that received the 
maximum quality rating for experimental design taking into consideration the above sources of 
error versus those that did not. Availability of repeated data would have helped address this issue 
further, but this was unavailable in most studies. Finally, the study populations were generally 
typical of patients presenting with clinical indications for coronary artery catheterization and, as 
such, there was a bias towards overweight, middle-to-older-aged men. Therefore, the findings 
cannot be widely generalized. 
Conclusions 
Cuff BP is the cornerstone method for hypertension management and physicians need to 
have confidence in its accuracy. The most important finding of the present study with respect to 
hypertension management was the inaccuracy of cuff BP when compared with intra-arterial 
brachial BP (underestimated SBP and PP; overestimated DBP) and aortic BP (wide variability 
for SBP; overestimated DBP; underestimated PP). These deviations substantially influenced BP 
classification according to clinical guideline criteria, with underestimation of cardiovascular risk 
being of largest concern to daily practice. While accepting the very important clinical role of cuff 
BP in general medicine, it is expected that the inadequacies identified within this work could be 
improved with better (more accurate) non-invasive cuff BP methods to estimate brachial or 
aortic BP. Notionally, this should then lead to reduced cardiovascular disease burden through 
enhanced clinical diagnosis and management of hypertension. 
  
Perspectives 
Competency in Medical Knowledge: There is substantial variability of cuff BP device accuracy 
for measurement of intra-arterial brachial or aortic BP. This theoretically has clinical 
implications, however, further studies are required to confirm this hypothesis. 
Translational Outlook: Development of new methods of BP measurement with improved 
accuracy is desirable. These methods should undergo robust validation to ensure high levels of 
accuracy.   
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Figure legends 
Central Illustration. Summary findings from individual participant data meta-analyses of 
cuff blood pressure (BP) accuracy. This illustration depicts BP classification based on cuff 
BP measurements and corresponding concordance with intra-arterial BP classification. The 
results are calculated using all available individual participant data from the 1950s 
to 2016. Reasonable confidence can be placed in cuff BP readings <120/80 or ≥160/100 mmHg 
to predict intra-arterial brachial or aortic BP. Improved accuracy is recommended in the BP 
range from prehypertension (≥120/80 to <140/90 mmHg) to stage 1 hypertension (≥140/90 to 
<160/100 mmHg), where concordance with intra-arterial BP was not strong. 
 
Figure 1. Forest plot of intra-arterial aortic and brachial BP difference. Pooled mean 
difference and 95% confidence interval for meta-analysis 1, the comparison of intra-arterial 
aortic and brachial systolic blood pressure (SBP, panel A), diastolic BP (DBP, panel B) and 
pulse pressure (PP, panel C). 
Figure 12. Forest plot of brachial cuff and intra-arterial brachial BP difference. Pooled 
mean difference and 95% confidence interval for meta-analysis 2, the comparison of brachial 
cuff and intra-arterial brachial systolic blood pressure (SBP, panel A), diastolic BP (DBP, panel 
B) and pulse pressure (PP, panel C). 
Figure 23. Forest plot of brachial cuff and intra-arterial aortic BP difference. Pooled mean 
difference and 95% confidence interval for meta-analysis 3, the comparison of brachial cuff and 
intra-arterial aortic systolic blood pressure (SBP, panel A), diastolic BP (DBP, panel B) and 
pulse pressure (PP, panel C). 
Figure 34. Individual brachial cuff and intra-arterial BP differences. Plots of brachial cuff 
and intra-arterial brachial (panel A), as well as brachial cuff and intra-arterial aortic (panel B) 
systolic blood pressure (BP). The mean of the brachial cuff systolic BP and intra-arterial systolic 
BP is on the x-axis and the mean difference between brachial cuff systolic BP and the intra-
arterial systolic BP is on the y-axis. The proportion of brachial cuff systolic BP values within 5 
mmHg of the intra-arterial systolic BP measures is represented by the dashed line (green), and 
reported under the 5 bar. The same presentation is provided for cuff systolic BP values within 
10 mmHg (dotted line (orange)) and 15 mmHg (dot-dashed line (red)). The solid black 
horizontal line represents a BP difference = 0 mmHg.  
Table 1. Number of subjects and percentage concordance between brachial cuff and intra-arterial brachial (panel A) and aortic (panel B) systolic 
and diastolic blood pressure (BP) for classification of BP control. 
A Intra-arterial brachial blood pressure 
n=668 Normal Prehypertension Stage 1 hypertension Stage 2 hypertension 
Cuff blood pressure 
SBP <120 and DBP<80 SBP 120-139 and/or DBP 80 – 
89 
SBP 140-159 and/or DBP 
90 – 99 
SBP≥160 or DBP≥100 
Normal                                                                       
SBP <120 and DBP<80Brachial 
cuff blood pressure 
Normal 
80 (60) 41 (35) 4 (4) 1 (1) 
Prehypertension                                                        
SBP 120-139 and/or DBP 80 – 89 
22 (9) 124 (50) 71 (36) 7 (5) 
Stage 1 hypertension                                                 
SBP 140-159 and/or DBP 90 – 99 
1 (2) 20 (13) 79 (53) 43 (32) 
Stage 2 hypertension                                         
SBP≥160 or DBP≥100 
0 (0) 1 (1) 31 (19) 143 (80) 
Prehypertension and stage 1 
hypertension combined           
SBP 120-159 and/or DBP 80 – 99 
23(6) 294 (78) 50 (16) 
B Intra-arterial aortic blood pressure 
N=1676 Normal Prehypertension Stage 1 hypertension Stage 2 hypertension 
  
Cuff blood pressure 
SBP <120 and DBP<80 SBP 120-139 and/or DBP 80 – 
89 
SBP 140-159 and/or DBP 
90 – 99 
SBP≥160 or DBP≥100 
Normal 
SBP <120 and DBP<80Brachial 
cuff blood pressure 
 
322 (79) 78 (19) 4 (1) 2 (1) 
Prehypertension 
SBP 120-139 and/or DBP 80 – 89 
112 (19) 341 (57) 130 (22) 13 (2) 
Stage 1 hypertension 
SBP 140-159 and/or DBP 90 – 99 
16 (4) 103 (24) 221 (52) 94 (20) 
Stage 2 hypertension 
SBP ≥160 or DBP ≥100 
0 (0) 7 (3) 48 (21) 185 (76) 
Prehypertension and stage 1 
hypertension combined 
SBP 120-159 and/or DBP 80 – 99 
 128 (6) 795 (78) 107 (16) 
Data are presented as n (%) and each row adds to 100%. Linear mixed modelling was used to account for clustering of subjects within studies. 
Brachial cuff BP measurements were classified based on JNC 7 guidelines, and compared for concordance by applying the same cut points to the with 
classification of the corresponding intra-arterial brachial (panel A) and aortic (panel B) systolic and diastolic BP. The proportion of intra-arterial 
brachial or aortic measurements concordant with brachial cuff BP is reported as a percentage. A value of 100% within the shaded boxes is equal to 
complete concordance of BP classification. According to JNC 7, normal BP <120/80 mmHg; prehypertension 120-139/80-89 mmHg; stage 1 
hypertension 140-159/90-99 mmHg and stage 2 hypertension ≥160/100 mmHg. Prehypertension and stage 1 hypertension were merged as a combined 
category to explore the possible clinical implication of cuff BP accuracy at this BP level. 
 
Table 2. Number of subjects and percentage concordance between brachial cuff and intra-arterial brachial (panel A) and aortic (panel B) systolic 
and diastolic blood pressure (BP) for classification of BP control based on revised intra-arterial thresholds. 
A 
 
Intra-arterial brachial blood pressure 
n=668 
 
Normal Prehypertension Stage 1 hypertension Stage 2 
hypertension 
Cuff blood pressure 
 SBP <124.5 and DBP 
<74 
SBP 124.5- <150 and/or 
DBP 74– <85 
SBP 150- <167 and/or 
DBP 85– <91 
SBP ≥167 or      
DBP ≥91 
 
Centiles <19th 19th – <54th 54th  - <76th   ≥76th 
Normal                                      
SBP <120 and DBP<80 
<19th  93 (71) 31 (27) 1 (1) 1 (1) 
Prehypertension 
SBP 120-139 and/or DBP 80 – 89 
19th – <54th 28 (13) 156 (66) 34 (17) 6 (4) 
Stage 1 hypertension 
SBP 140-159 and/or DBP 90 – 99 
54th  - <76th   3 (2) 38 (26) 73 (52) 29 (20) 
Stage 2 hypertension 
SBP≥160 or DBP≥100 
≥76th  0 (0)  6(3) 31 (21) 138 (76) 
Prehypertension and stage 1 
hypertension combined 
SBP 120-159 and/or DBP 80 – 99 
19th – <76th 31 (9) 301 (81) 35 (10) 
B   Intra-arterial aortic blood pressure 
n=1676   Normal           Prehypertension     Stage 1 hypertension   Stage 2 
hypertension      
Cuff blood pressure  SBP <119.1 and DBP 
<74 
SBP 119.1-141.8 and/or 
DBP 74 – 83.5 
SBP 141.8-165.1 and/or 
DBP 83.5–93.1 
SBP ≥ 165.1 or 
DBP ≥ 93.1 
 Centiles <24
th  24th - <59th 59th – 86th ≥86th 
Normal                                    
SBP <120 and DBP<80 
<24th 302 (74) 97 (25) 6 (1) 1 (0) 
Prehypertension                     
SBP 120-139 and/or DBP 80 – 89 
24th - <59th  89 (15) 364 (61) 133 (22) 10 (2) 
Stage 1 hypertension             
SBP 140-159 and/or DBP 90 – 99 
59th – <86th  14 (3) 108 (27) 245 (56) 67 (14) 
Stage 2 hypertension             
SBP ≥160 or DBP ≥100  
≥86th  0 (0) 8 (5) 66 (30) 166 (65) 
Prehypertension and stage 1 
hypertension combined 
SBP 120-159 and/or DBP 80 – 99 
24th - <86th  103 (10) 850 (83) 77(7) 
 Data are presented as n (%) and each row adds to 100%. Linear mixed modelling was used to account for clustering of subjects within studies. Brachial 
cuff BP measurements were classified based on JNC 7 guidelines, and compared for concordance with classification of the corresponding intra-arterial 
brachial (panel A) and aortic (panel B) systolic and diastolic BP. The proportion of intra-arterial brachial or aortic measurements concordant with brachial 
cuff BP is reported as a percentage. A value of 100% within the shaded boxes is equal to complete concordance of BP classification. Modified intra-arterial 
thresholds have been calculated from the equivalent percentile rank of cuff BP thresholds. Prehypertension and stage 1 hypertension were merged as a 
combined category to explore the possible clinical implication of cuff BP accuracy at this BP level. 
 
